Lantern Pharma Inc. (LTRN)
NASDAQ: LTRN · Real-Time Price · USD
3.420
+0.140 (4.27%)
Nov 7, 2024, 4:00 PM EST - Market closed
Lantern Pharma Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 7, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 37 | 47 | 66 | 89 | 120 | - | |
| Market Cap Growth | -17.95% | -29.06% | -26.55% | -25.41% | - | - | |
| Enterprise Value | 3 | 2 | 8 | 16 | 99 | - | |
| Last Close Price | 3.31 | 4.28 | 6.04 | 7.98 | 19.25 | - | |
| PE Ratio | - | -2.91 | -4.60 | -7.04 | -14.03 | - | |
| PB Ratio | 1.15 | 1.14 | 1.17 | 1.25 | 6.08 | - | |
| P/FCF Ratio | -3.29 | -3.24 | -5.13 | -8.42 | -21.12 | - | |
| P/OCF Ratio | -3.29 | -3.24 | -5.14 | -8.43 | -21.18 | - | |
| EV/EBITDA Ratio | -0.62 | -0.10 | -0.54 | -1.35 | -16.77 | - | |
| EV/EBIT Ratio | -0.62 | -0.10 | -0.54 | -1.35 | -16.76 | - | |
| EV/FCF Ratio | -0.79 | -0.13 | -0.61 | -1.48 | -17.47 | - | |
| Debt / Equity Ratio | 0.01 | 0.01 | 0.00 | 0.00 | 0.01 | - | |
| Debt / FCF Ratio | -0.01 | -0.02 | 0.00 | -0.02 | -0.02 | - | |
| Quick Ratio | 7.23 | 15.74 | 19.94 | 30.48 | 34.81 | 2.52 | |
| Current Ratio | 7.67 | 16.18 | 20.99 | 31.26 | 36.64 | 2.52 | |
| Return on Equity (ROE) | -44.82% | -32.93% | -22.35% | -27.09% | -57.24% | -654.95% | |
| Return on Assets (ROA) | -28.07% | -21.81% | -13.59% | -15.36% | -33.89% | -161.24% | |
| Return on Capital (ROIC) | -30.64% | -22.98% | -14.11% | -15.82% | -35.59% | -409.34% | |
| Earnings Yield | -49.81% | -34.31% | -21.75% | -13.85% | -4.94% | - | |
| FCF Yield | -42.86% | -30.88% | -19.51% | -11.88% | -4.74% | - | |
| Buyback Yield / Dilution | 0.58% | 0.08% | 0.50% | -153.31% | -117.61% | -2.67% | |
| Total Shareholder Return | 0.58% | 0.08% | 0.50% | -153.31% | -117.61% | -2.67% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.